We are live on ! Find out more
Nisa Investment Advisors

Nisa Investment Advisors Portfolio holdings

AUM $32B
1-Year Est. Return 32.86%
This Fund
S&P 500
This Quarter Est. Return
+8.93%
1 Year Est. Return
+32.86%
3 Year Est. Return
+108.44%
5 Year Est. Return
+138.89%
10 Year Est. Return
+505.54%
AUM
$12.8B
AUM Growth
+$89.4M
Cap. Flow
-$680M
Cap. Flow %
-5.33%
Top 10 Hldgs %
21.18%
Holding
2,833
New
113
Increased
921
Reduced
935
Closed
132

Top Buys

Rank Stock Value
1
LIN icon
Linde
LIN
+$10.2M
2
VZ icon
Verizon
VZ
+$7.09M
3
VCLT icon
Vanguard Long-Term Corporate Bond ETF
VCLT
+$6.96M
4
TSLA icon
Tesla
TSLA
+$6.65M
5
GEHC icon
GE HealthCare
GEHC
+$5.59M

Top Sells

Rank Stock Value
1
TSM icon
TSMC
TSM
+$86.2M
2
VTI icon
Vanguard Morningstar Total Stock Market ETF
VTI
+$69.9M
3
ASML icon
ASML
ASML
+$49.2M
4
CCI icon
Crown Castle
CCI
+$29.4M
5
BIDU icon
Baidu
BIDU
+$28.5M

Sector Composition

Rank Sector Weight
1 Technology 23.54%
2 Healthcare 12.75%
3 Financials 11.59%
4 Consumer Discretionary 9.05%
5 Industrials 8.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALKT icon
2501
Alkami Technology
ALKT
$2.1B
$0 ﹤0.01%
5
-1,400
-100% -$20.7K
ALRS icon
2502
Alerus Financial
ALRS
$827M
$0 ﹤0.01%
19
-3,731
-99% -$73.9K
AMPY icon
2503
Amplify Energy
AMPY
$172M
$0 ﹤0.01%
+25
New +$205
AMTX icon
2504
Aemetis
AMTX
$120M
-15
Closed
ANTX icon
2505
AN2 Therapeutics
ANTX
$213M
$0 ﹤0.01%
10
ARKO icon
2506
ARKO Corp
ARKO
$527M
-72
Closed -$1K
ARQT icon
2507
Arcutis Biotherapeutics
ARQT
$3.26B
-13,900
Closed -$206K
ASML icon
2508
ASML
ASML
$666B
-90,000
Closed -$49.2M
ASPN icon
2509
Aspen Aerogels
ASPN
$522M
-39
Closed
ASX icon
2510
ASE Group
ASX
$82.7B
-386,000
Closed -$2.42M
LONA
2511
LeonaBio Inc
LONA
$70.5M
$0 ﹤0.01%
4
-456
-99% -$14.7K
AVD icon
2512
American Vanguard Corp
AVD
$65.5M
$0 ﹤0.01%
15
-17
-53% -$366
AVIR icon
2513
Atea Pharmaceuticals
AVIR
$402M
-120
Closed -$1K
JBIO
2514
Jade Biosciences
JBIO
$1.32B
0
BANC icon
2515
Banc of California
BANC
$3B
$0 ﹤0.01%
20
-50
-71% -$808
BARK icon
2516
BARK
BARK
$96.7M
$0 ﹤0.01%
7
-241
-97% -$7.64K
BATL icon
2517
Battalion Oil
BATL
$31M
-18
Closed
BEKE icon
2518
KE Holdings
BEKE
$19.5B
-979,000
Closed -$13.7M
BIDU icon
2519
Baidu
BIDU
$37.1B
-249,000
Closed -$28.5M
BIRD icon
2520
Smartbird Inc
BIRD
$22.7M
-10
Closed
BKKT icon
2521
Bakkt Inc
BKKT
$342M
$0 ﹤0.01%
8
-514
-98% -$20K
BMRC icon
2522
Bank of Marin Bancorp
BMRC
$455M
$0 ﹤0.01%
+10
New +$289
BRCC icon
2523
BRC Inc
BRCC
$216M
$0 ﹤0.01%
43
+24
+126% +$151
BTAI icon
2524
BioXcel Therapeutics
BTAI
$28.7M
$0 ﹤0.01%
1
BV icon
2525
BrightView Holdings
BV
$1.05B
$0 ﹤0.01%
+54
New +$364

Similar funds

Nisa Investment Advisors's Q1 2023 Portfolio in Review

As of Q1 2023, Nisa Investment Advisors held 2,833 positions worth $12.8B, up 0.71% from $12.7B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Nisa Investment Advisors withdrew a net $680M in Q1 2023, closing 132 positions and reducing 935 holdings. Its most notable exit was Vanguard Morningstar Total Stock Market ETF, an estimated $69.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Nisa Investment Advisors opened a new position in GE HealthCare worth $6.42M.

  • Nisa Investment Advisors's largest Q1 2023 buy was GE HealthCare: 78,261 shares worth $6.42M.
  • Nisa Investment Advisors added most to Linde in Q1 2023, an estimated $10.2M increase.
  • Nisa Investment Advisors's biggest Q1 2023 reduction was TSMC, cutting an estimated $86.2M.
  • Nisa Investment Advisors fully exited Vanguard Morningstar Total Stock Market ETF in Q1 2023, selling an estimated $69.9M.
  • Nisa Investment Advisors's ten largest holdings make up 21% of its $12.8B portfolio in Q1 2023.
  • Nisa Investment Advisors opened 113 new positions and closed 132 in Q1 2023.
  • Nisa Investment Advisors's portfolio value rose 0.71% quarter-over-quarter to $12.8B.

Based on Nisa Investment Advisors's 13F filing for Q1 2023, filed 2 May 2023.